Loading...
Please wait, while we are loading the content...
Similar Documents
The power of 1 in HIV therapeutics
| Content Provider | Scilit |
|---|---|
| Author | Parker, Raphaelle Sereti, Irini |
| Copyright Year | 2011 |
| Description | In this issue of Blood, Allers and colleagues describe the long-term follow-up of their previously reported HIV+ patient who was treated with allogeneic CCR5Δ32/Δ32 stem cell transplantation (SCT) for relapsed acute myeloid leukemia $(AML).^{1,2}$ The patient has since remained off antiretroviral therapy (ART) and without evidence of HIV disease for 45 months after the SCT despite relapse of his AML, which necessitated a second successful transplantation. |
| Related Links | http://www.bloodjournal.org/content/117/10/2746.full.pdf |
| Ending Page | 2747 |
| Page Count | 2 |
| Starting Page | 2746 |
| DOI | 10.1182/blood-2011-01-324921 |
| Journal | Blood |
| Issue Number | 10 |
| Volume Number | 117 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2011-03-10 |
| Access Restriction | Open |
| Subject Keyword | Hematology Hiv Relapsed Aml Allogeneic Leukemia Myeloid Sct Colleagues Allers Journal: Blood (Vol- 114, Issue- 10) |
| Content Type | Text |
| Resource Type | Article |